Spero Therapeutics (SPRO) Current Taxes (2023 - 2026)
Spero Therapeutics posted quarterly Current Taxes of $163000.0 for Q1 2026, down 6.32% year-on-year from $174000.0 in Q1 2025, and down 57.44% on a QoQ basis from $383000.0 in Q4 2025.
Spero Therapeutics (SPRO) has 4 years of Current Taxes data on file, last reported at $163000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Taxes fell 6.32% year-over-year to $163000.0; the trailing twelve-month figure through Mar 2026 stood at $163000.0 (down 6.32% YoY), and the FY2025 full-year result was $383000.0, up 120.11% from the prior year.
- Current Taxes for Q1 2026 stood at $163000.0, down from $383000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $2.2 million in Q3 2023 and bottomed at $97000.0 in Q3 2024.
- The 4-year median for Current Taxes is $174000.0 (2024), against an average of $426272.7.
- The widest annual swing landed in 2024, when Current Taxes sank 95.61%; it then surged 120.11% in 2025.
- A 4-year view of Current Taxes shows it stood at $387000.0 in 2023, then tumbled by 55.04% to $174000.0 in 2024, then soared by 120.11% to $383000.0 in 2025, then plunged by 57.44% to $163000.0 in 2026.
- The last three Current Taxes figures came in at $163000.0 (Q1 2026), $383000.0 (Q4 2025), and $163000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 10,460.56 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 19.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 163,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 163,000.00 |
| Dec 31, 2025 | 383,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 163,000.00 |
| Mar 31, 2025 | 174,000.00 |
| Dec 31, 2024 | 174,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 387,000.00 |
| Dec 31, 2023 | 387,000.00 |
| Sep 30, 2023 | 2.21 Mn |